3HP for Latent TB Infection Treatment | 2018 | Newsroom | NCHHSTP

June 28, 2018 – 3HP for Latent TB Infection Treatment

CDC released updated recommendations for use of once-weekly isoniazid-rifapentine for 12 weeks (3HP) for treatment of latent tuberculosis (TB) infection. The updated recommendations support expanded use of an effective, shorter, treatment regimen to reach even more people with latent TB infection. The 3HP regimen can help remove current barriers to latent TB treatment for both patients and providers.